News

Tagrisso paired with Hutchmed drug clears lung cancer test

Phil Taylor AstraZeneca, HutchMed, Non-small cell lung cancer, Oncology, Orpathys, Tagrisso, targeted oncology 0 Comment

EGFR inhibitors like AstraZeneca’s Tagrisso have been hugely successful in treating EGFR-positive lung cancer, but the durability of

Tagrisso paired with Hutchmed drug clears lung cancer test

https://pharmaphorum.com/news/tagrisso-paired-with-hutchmed-drug-clears-lung-cancer-test/

Digital/ News/ News/ News/ Oncology

FDA okays ProstatID software for detecting prostate cancer in MRI

Phil Taylor artificial intelligence, Bot Imaging, digital, digital health, MRI, Oncology, Prostate cancer, ProstatID 0 Comment

Magnetic resonance imaging (MRI) technology specialist Bot Image has won FDA approval for its artificial intelligence-powered software ProstatID,

FDA okays ProstatID software for detecting prostate cancer in MRI

https://pharmaphorum.com/news/fda-okays-prostatid-software-for-detecting-prostate-cancer-in-mri/

News/ News/ R&D

Karuna Therapeutics scores phase 3 win for schizophrenia therapy KarXT

Eloise McLennan clinical trial, Karuna Therapeutics, pharma, R&D, schizophreina 0 Comment

Karuna Therapeutics has unveiled positive topline results from its phase 3 EMERGENT-2 trial evaluating the efficacy, safety, and

Karuna Therapeutics scores phase 3 win for schizophrenia therapy KarXT

https://pharmaphorum.com/news/karuna-therapeutics-scores-phase-3-win-for-schizophrenia-therapy-karxt/

News/ News/ Sales and Marketing

Pfizer vaults into sickle cell market as GBT deal confirmed

Phil Taylor Global Blood Therapeutics, M&A, Oxbryta, Pfizer, sickle cell disease 0 Comment

Pfizer’s reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT) has been confirmed, with the

Pfizer vaults into sickle cell market as GBT deal confirmed

https://pharmaphorum.com/news/pfizer-vaults-into-sickle-cell-market-as-gbt-deal-confirmed/

News/ News/ News/ Oncology/ Sales and Marketing

Bayer bags swift OK for Nubeqa in metastatic prostate cancer

Phil Taylor Bayer, Erleada, Nubeqa, Oncology, Orion, Prostate cancer, regulatory approval, Xtandi 0 Comment

Bayer has won a key FDA approval to extend the use of its prostate cancer therapy Nubeqa, as

Bayer bags swift OK for Nubeqa in metastatic prostate cancer

https://pharmaphorum.com/news/bayer-bags-swift-ok-for-nubeqa-in-metastatic-prostate-cancer/

Digital/ News/ News

Digital health app linked to better outcomes in heart failure

Phil Taylor cardiovascular, digital, digital health, HealthStar, heart failure, Pattern Health Technologies 0 Comment

A study of a mobile health app used to support patients hospitalised with heart failure has concluded that

Digital health app linked to better outcomes in heart failure

https://pharmaphorum.com/news/digital-health-app-linked-to-better-outcomes-in-heart-failure/

Market Access/ News/ News/ News/ Oncology

AZ gets FDA nod for Enhertu in first HER2-low cancer

Phil Taylor AstraZeneca, breast cancer, Enhertu, fda, her2, Oncology, regulatory approval 0 Comment

The FDA has approved AstraZeneca and Daiichi Sankyo’s Enhertu as the first targeted therapy for HER2-low breast cancer,

AZ gets FDA nod for Enhertu in first HER2-low cancer

https://pharmaphorum.com/news/az-gets-fda-nod-for-enhertu-in-first-her2-low-cancer/

News

Azithromycin for mild-to-moderate COVID-19

Eloise McLennan antibiotics, bacterial infections, COVID-19, treatment 0 Comment

Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and

Azithromycin for mild-to-moderate COVID-19

https://pharmaphorum.com/news/azithromycin-for-mild-to-moderate-covid-19/

News/ News/ Sales and Marketing

Pfizer bid for sickle cell drug developer GBT said to be imminent

Phil Taylor Global Blood Therapeutics, M&A, Oxbryta, Pfizer, sickle cell disease 0 Comment

Pfizer is on the brink of announcing a deal to buy Global Blood Therapeutics (GBT) and its oral

Pfizer bid for sickle cell drug developer GBT said to be imminent

https://pharmaphorum.com/news/pfizer-bid-for-sickle-cell-drug-developer-gbt-said-to-be-imminent/

«‹ 3 4 5 6 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

News

Login